Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function-Reference-Cited by-同舟云学术

Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function

Published:2023-06-21 Issue:7 Volume:39 Page:947-953
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Ke Jiahan¹,Pan Jianan¹,Lin Hao¹,Han Zhihua¹,Gu Jun¹

Affiliation:

1. Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China

Funder

the Clinical Research Program

Biobank for Coronary Heart Disease

Natural Science Foundation of Shanghai

Project from Shanghai Health Commission

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2223916

Reference22 articles.

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension

2. Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension

3. 2020 American College of Rheumatology Guideline for the Management of Gout

4. Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition

5. Epidemiology of heart failure with preserved ejection fraction

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28

2. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease;Cells;2024-03-04